* Austin cites co's deteriorating performance

* Shares up 43 pct

July 6 (Reuters) - Chelsea Therapeutics International Ltd's largest shareholder has urged the board to explore alternative approaches after the company's key experimental drug hit another regulatory road block, sending its shares up 43 percent.